Search results
Results from the WOW.Com Content Network
Baxter's interest was bought out in 1935 by Ralph Falk, who established a research and development function. [5] In 1939 the company developed a vacuum-type collection container, extending the shelf life of blood from hours to weeks. [5] In 1954, the company expanded operations outside of the United States by opening an office in Belgium. [6]
Deerfield is home to the headquarters of Walgreens Boots Alliance, Baxter Healthcare, and Fortune Brands Home & Security. Deerfield is often listed among the wealthiest and highest-earning places in Illinois and the Midwest. According to the United States Census Bureau, the median household income in Deerfield was $185,762 in 2022. [3]
Hillrom is a wholly owned subsidiary of Baxter and was formally part of Hill-Rom Holdings, Inc., which was formerly a part of Hillenbrand Industries until that company split its medical equipment division from their casket business in 2008. [3] Their headquarters are in Chicago, Illinois. [3] John Groetelaars was the President and CEO. [4]
Baxter sold its BioPharma Solutions business in October for $4.25 billion to investment firms. The new company, Simtra, wants to expand.
Genovese Drug Stores (acquired by Eckerd parent JC Penney in 1998; rebranded in 2003) Gray Drug (Bought by Rite Aid in 1987) Happy Harry's (bought by Walgreens in 2006; rebranded in 2011) Hook's Drug Stores (acquired by Revco in 1994) IDL Drug Stores; Jean Coutu (US stores acquired by Rite Aid in 2004) K&B (Acquired by Rite Aid in 1997)
This page was last edited on 28 December 2021, at 16:02 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
NEW YORK (Reuters) -Buyout firm Carlyle Group struck a deal to acquire Baxter’s kidney-care unit Vantive for $3.8 billion, the companies said on Tuesday. In 2022, Baxter started exploring ...
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.